Cargando…
Immune Landscape and an RBM38-Associated Immune Prognostic Model with Laboratory Verification in Malignant Melanoma
SIMPLE SUMMARY: The primary treatment of malignant melanoma is a classical regimen of surgery combined with chemotherapy, targeted drugs, and immunotherapy. The purpose of this study was to explore the immune response mechanism of RNA binding protein RBM38 in the development of melanoma with the scr...
Autores principales: | Liu, Jinfang, Xu, Jun, Luo, Binlin, Tang, Jian, Hou, Zuoqiong, Zhu, Zhechen, Zhu, Lingjun, Yao, Gang, Li, Chujun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946480/ https://www.ncbi.nlm.nih.gov/pubmed/35326741 http://dx.doi.org/10.3390/cancers14061590 |
Ejemplares similares
-
Application of an indocyanine green surgical fluorescence imaging system in sentinel lymph node biopsy of acral malignant melanoma
por: Jiang, Keyu, et al.
Publicado: (2021) -
Circular RNA circRNA_0082835 promotes progression and lymphatic metastasis of primary melanoma by sponging microRNA miRNA-429
por: Sun, Yute, et al.
Publicado: (2021) -
Necroptosis-related LncRNAs in skin cutaneous melanoma: evaluating prognosis, predicting immunity, and guiding therapy
por: Liu, Jianlan, et al.
Publicado: (2023) -
Effects of RNA methylation N6-methyladenosine regulators on malignant progression and prognosis of melanoma
por: Liu, Jinfang, et al.
Publicado: (2021) -
Liquid-liquid phase separation throws novel insights into treatment strategies for skin cutaneous melanoma
por: Liu, Jianlan, et al.
Publicado: (2023)